SMMT Summit Therapeutics Inc.
$17.15
▼ 3.92%
23
Value
25
P/E-12.64
8
P/B32.12
25
P/S0.00
70
EV/EBITDA-12.48
5
Growth
22
Revenue Growth0.0%
28
EPS Growth-476.0%
11
FCF Growth-111.3%
32
Momentum
49
12-Month Return-29.1%
25
3-Month Return23.8%
98
1-Month Return-8.8%
37
RSI (14)23.92
60
50/200 MABearish
30
Profitability
9
ROE-340.6%
0
ROA-214.2%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-2.2%
0
Risk
5
Beta-1.25
10
60-Day Volatility91.2%
0
QScore Analysis